OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 07, 2021
The $3 million investment will go towards various projects investigating key product attributes for therapeutic proteins.
September 24, 2021
The first part of the 2021 CPhI Annual Report has been published and predicts a strong outlook for CDMOs over the next few years.
April 23, 2021
Executives that participated in the CPhI post-pandemic survey are predicting a push for repatriation of manufacturing globally.
March 23, 2021
CPhI’s post-pandemic report predicts strong progression in pharma innovation, with breakthroughs in multi-modal disease therapies, a transformative effect of mRNA platforms, and significant growth in contract services.
January 22, 2021
CPhI China event organizers are encouraged by the success of the recent event and claim that it demonstrates a reassuring return to form for pharma events in 2021, which will also fuel a boom for the industry.
January 19, 2021
The CPhI event, which was originally scheduled for Aug. 31–Sept. 2, 2021 at the Fiera Milano in Milan, Italy, will be rescheduled for Nov. 9–11, 2021 at the same venue.
November 12, 2020
Analysis from the CPhI Annual Report has revealed that the global contract services sector is benefitting from a switch toward COVID-19 manufacturing and clinical-stage contracts; however, mega-cap pharma innovation is slowing outsourcing.
October 22, 2020
The third part of the CPhI annual report has predicted a significant amount of pressure will be placed on bioprocessing networks should COVID-19 biologics gain approval.
October 15, 2020
The judges chose Sheng from a shortlist of seven candidates and highlighted his work in the Taiwanese and global markets while guiding the company through “pivotal changes” that demonstrated his abilities as a “top CEO.”
October 13, 2020
The winners were announced during day seven of CPhI Festival of Pharma.